JP2009500398A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009500398A5 JP2009500398A5 JP2008520121A JP2008520121A JP2009500398A5 JP 2009500398 A5 JP2009500398 A5 JP 2009500398A5 JP 2008520121 A JP2008520121 A JP 2008520121A JP 2008520121 A JP2008520121 A JP 2008520121A JP 2009500398 A5 JP2009500398 A5 JP 2009500398A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- subject
- preparation
- transdermal
- olopatadine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000009472 formulation Methods 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- JBIMVDZLSHOPLA-LSCVHKIXSA-N olopatadine Chemical compound C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCN(C)C)\C2=CC=CC=C21 JBIMVDZLSHOPLA-LSCVHKIXSA-N 0.000 claims 2
- 229960004114 olopatadine Drugs 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 230000000172 allergic effect Effects 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 208000030533 eye disease Diseases 0.000 claims 1
- 210000000744 eyelid Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69736805P | 2005-07-08 | 2005-07-08 | |
| US60/697,368 | 2005-07-08 | ||
| PCT/JP2006/314017 WO2007007863A1 (en) | 2005-07-08 | 2006-07-07 | Percutaneously absorptive ophthalmic preparation comprising olopatadine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009500398A JP2009500398A (ja) | 2009-01-08 |
| JP2009500398A5 true JP2009500398A5 (enExample) | 2009-08-20 |
| JP5315051B2 JP5315051B2 (ja) | 2013-10-16 |
Family
ID=37022903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008520121A Expired - Fee Related JP5315051B2 (ja) | 2005-07-08 | 2006-07-07 | オロパタジンを含む眼科用経皮吸収型製剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8101654B2 (enExample) |
| EP (1) | EP1901708B1 (enExample) |
| JP (1) | JP5315051B2 (enExample) |
| KR (1) | KR20080038335A (enExample) |
| CN (1) | CN101217937A (enExample) |
| ES (1) | ES2437077T3 (enExample) |
| WO (1) | WO2007007863A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20120035220A (ko) * | 2003-01-22 | 2012-04-13 | 센주 세이야꾸 가부시키가이샤 | 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환 치료약의 눈의 국소 조직으로의 이행 방법 |
| CN101217948A (zh) * | 2005-07-08 | 2008-07-09 | 千寿制药株式会社 | 包含依匹那丁的透皮吸收眼科制剂 |
| WO2008026756A1 (en) * | 2006-08-28 | 2008-03-06 | Senju Pharmaceutical Co., Ltd. | Ophthalmic percutaneous absorption type preparation |
| EP2493475A4 (en) | 2009-10-30 | 2014-10-29 | Intratus Inc | COSMETIC METHODS AND PREPARATIONS FOR THE PROLONGED RELEASE OF THERAPEUTIC AGENTS IN THE EYE |
| US8900626B2 (en) | 2011-06-20 | 2014-12-02 | Senju Usa, Inc. | Transdermal drug delivery system and method of using the same |
| KR101891144B1 (ko) * | 2012-12-19 | 2018-08-23 | 에스에이알코드 바이오사이언스 인코포레이티드 | Lfa-1 저해제 제형 |
| WO2016182032A1 (ja) * | 2015-05-12 | 2016-11-17 | 参天製薬株式会社 | アゾール系抗真菌薬の眼瞼皮膚への投与 |
| CN106324111A (zh) * | 2015-06-24 | 2017-01-11 | 江苏吉贝尔药业股份有限公司 | 一种盐酸奥洛他定滴眼液的检测方法 |
| TWI825013B (zh) * | 2017-04-19 | 2023-12-11 | 日商帝國製藥股份有限公司 | 含有盧帕他定（ｒｕｐａｔａｄｉｎｅ）之貼附劑 |
| CN107823124B (zh) * | 2017-11-09 | 2018-11-27 | 广州博济医药生物技术股份有限公司 | 一种盐酸奥洛他定外用组合物及其乳膏剂 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6310784A (ja) | 1986-03-03 | 1988-01-18 | Kyowa Hakko Kogyo Co Ltd | 抗アレルギー剤 |
| US5641805A (en) | 1995-06-06 | 1997-06-24 | Alcon Laboratories, Inc. | Topical ophthalmic formulations for treating allergic eye diseases |
| US5744151A (en) * | 1995-06-30 | 1998-04-28 | Capelli; Christopher C. | Silver-based pharmaceutical compositions |
| JPH09194396A (ja) * | 1996-01-17 | 1997-07-29 | Pola Chem Ind Inc | 貼付剤用マトリックス |
| DE60008730T2 (de) * | 1999-06-18 | 2004-08-05 | Alcon Manufacturing Ltd., Fort Worth | Methode zur konzentrationsbestimmung einer amphipathischen antihistaminischen verbindung durch bestimmung ihrer oberflächen aktivitäts einstufung |
| JP4627945B2 (ja) * | 1999-07-15 | 2011-02-09 | 久光製薬株式会社 | 経皮吸収製剤 |
| JP4653893B2 (ja) * | 2000-01-27 | 2011-03-16 | 純一 須藤 | 二層型経皮吸収製剤 |
| TWI231759B (en) | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
| KR20120035220A (ko) | 2003-01-22 | 2012-04-13 | 센주 세이야꾸 가부시키가이샤 | 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환 치료약의 눈의 국소 조직으로의 이행 방법 |
-
2006
- 2006-07-07 EP EP06781092.9A patent/EP1901708B1/en not_active Not-in-force
- 2006-07-07 US US11/988,377 patent/US8101654B2/en not_active Expired - Fee Related
- 2006-07-07 ES ES06781092.9T patent/ES2437077T3/es active Active
- 2006-07-07 WO PCT/JP2006/314017 patent/WO2007007863A1/en not_active Ceased
- 2006-07-07 CN CNA2006800248918A patent/CN101217937A/zh active Pending
- 2006-07-07 JP JP2008520121A patent/JP5315051B2/ja not_active Expired - Fee Related
- 2006-07-07 KR KR1020087003138A patent/KR20080038335A/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011516477A5 (enExample) | ||
| JP2010502564A5 (enExample) | ||
| JP2011520805A5 (enExample) | ||
| JP2009501797A5 (enExample) | ||
| JP2022008403A5 (enExample) | ||
| JP2011521969A5 (enExample) | ||
| JP2009535162A5 (enExample) | ||
| IL208982B (en) | A preparation containing baclofen or a salt, derivative or delayed release formulation thereof for use in the treatment of Alzheimer's disease | |
| JP2009500398A5 (enExample) | ||
| NZ588938A (en) | Sustained release delivery of active agents to treat glaucoma and ocular hypertension | |
| WO2008137863A3 (en) | Methods and devices for measuring tear film and diagnosing tear disorders | |
| JP2011510014A5 (enExample) | ||
| BRPI0818621A2 (pt) | composição farmacêutica, e, métodos para reduzir a carga da placa e a quantidade de planas na camada de célula de gânglio retinal de um indivíduo, para prevenir, tratar e/ou aliviar os efeitos de uma doença ocular, para diagnosticar uma doença ocular e uma predisposição a uma doença ocular, para monitorar doença ocular, para predizer responsividade de um paciente, e para reter ou diminuir pressão ocular nos olhos de um indivíduo | |
| BRPI0818623A2 (pt) | composição farmacêutica, e, métodos para reduzir a carga da placa na camada de célula de gânglio retinal de um animal, para reduzir a quantidade de placas na camada de célula de gânglio retinal de um animal, para diminuir a quantidade total de amilóide-beta solúvel na camada de célula de gânglio retinal de um animal, para prevenir, tratar e/ou aliviar os efeitos de uma doença ocular associada com anormalidades patológicas/mudanças no tecido do sistema visual, para monitorar doença ocular residual mínima associada com anormalidades patológicas/mudanças nos tecidos do sistema visual, para predizer responsividade de um paciente, e para reter ou diminuir a pressão ocular nos olhos de um animal | |
| JP2010222367A5 (enExample) | ||
| JP2009500397A5 (enExample) | ||
| JP2012523430A5 (enExample) | ||
| JP2013534527A5 (enExample) | ||
| HRP20130123T1 (hr) | Postupak lijeäśenja bolesti | |
| AR062395A1 (es) | Uso de derivados del 2.5-dihidroxibenceno para el tratamiento de enfermedades oculares | |
| MX350195B (es) | Analogos de cistamina para el tratamiento de la enfermedad de parkinson. | |
| ME02608B (me) | Kombinacija, komplet i postupak snižavanja intraokularnog pritiska | |
| WO2013184650A3 (en) | Treatment of ocular inflammatory diseases using laquinimod | |
| RU2018102746A (ru) | Офтальмологическая фармацевтическая композиция | |
| JP2019502719A5 (enExample) |